Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,470.00
(
-1.06%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
106.93
(
0.00%
)
Bitcoin
70,555.46
(
0.06%
)
News Focus
News Focus
Post# of 19309
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 28
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 3697

Saturday, 06/02/2007 5:18:05 AM

Saturday, June 02, 2007 5:18:05 AM

Post# of 19309
Inhaled Alpha-1 Antitrypsin - Kamada
In a conference I attended on May, David Tsur kamada's CEO said that they already know that the inhaled dose is about 25% of the injectable one. Given the limitation of plasma supply, these are good news.
If efficacy will work fine, they will try the inhaled delivery for other indications such as Cistic Fibrosis which suppose to be more profitable.

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today